Table 1.
Classification of participants with mild platelet-based bleeding defects
Type of platelet defect | No. of participants | % of participants |
---|---|---|
Membrane Gi signaling | 21 | 32.8% |
TxA2 pathway | 14 | 21.9% |
GPVI | 4 | 6.2% |
Gq | 1 | 1.6% |
Dense granule | 19 | 29.7% |
Complex | 5 | 7.8% |
Total | 64 | 100% |
Participants who exhibited a defect in platelet function were subdivided on the basis of their major platelet phenotype, as described in the text.